Research paperThe bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)—I: Purification and properties of a nitroreductase enzyme from Escherichia coli—A potential enzyme for antibody-directed enzyme prodrug therapy (ADEPT)
References (22)
- et al.
2,4-Dinitro-5-ethyleneiminobenzamide (CB1954); a potent and selective inhibitor of the growth of the Walker carcinoma 256
Chem Pharmacol
(1969) - et al.
CB1954 (2,4-dinitro-5-aziridinyl benzamide) becomes a DNA interstrand crosslinking agent in Walker tumour cells
Biochem Biophys Res Commun
(1986) - et al.
A new cytotoxic, DNA interstrand crosslinking agent; 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide, is formed from 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954) by a nitroreductase enzyme in Walker carcinoma cells
Biochem Pharmacol
(1988) - et al.
The nitroreductase enzyme in Walker cells that activates 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954) to 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide is a form of NAD(P)H dehydrogenase (quinone) (EC 1.6.99.2)
Biochem Pharmacol
(1988) - et al.
DT-diaphorase and cancer chemotherapy
Biochem Pharmacol
(1992) The differential response of resistant and sensitive strains of Escherichia coli to the cytotoxic effects of 5-aziridino-2,4-dinitrobenzamide (CB1954)
Chem Biol Interact
(1971)- et al.
Caffeine, aminoimidazolecarboxamide and dicoumarol, inhibitors of NAD(P)H dehydrogenase (quinone) (DT diaphorase), prevent both the cytotoxicity and DNA interstrand crosslinking produced by 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954) in Walker cells
Biochem Pharmacol
(1989) - et al.
Characterization of FMN-dependent NADH-quinone reductase induced by menadione in Escherichia coli
Biochim Biophys Acta
(1990) - et al.
Cloning, nucleotide sequence and expression of the nitroreductase gene from Enterobacter cloacae
J Biol Chem
(1991) - et al.
Mutagenicity and genotoxicity of nitroarenes. All nitro-containing chemicals were not created equal
Mutat Res
(1983)
Cited by (197)
All-in-one IQ toggle switches with high versatilities for fine-tuning of transgene expression in mammalian cells and tissues
2024, Molecular Therapy Methods and Clinical DevelopmentChemical screening reveals Ronidazole is a superior prodrug to Metronidazole for nitroreductase-induced cell ablation system in zebrafish larvae
2021, Journal of Genetics and GenomicsInteractions of the antioxidant enzymes NAD(P)H: Quinone oxidoreductase 1 (NQO1) and NRH: Quinone oxidoreductase 2 (NQO2) with pharmacological agents, endogenous biochemicals and environmental contaminants
2021, Chemico-Biological InteractionsCitation Excerpt :However, metabolic activation is necessary to activate it into a potent cytotoxic anticancer agent. NQO1 (DT-diaphorase at the time) was initially found by virtue of its nitroreductase activity to carry out reductive activation of CB1954 (Fig. 4) [51,52]. CB1954 active metabolites (hydroxylamine or nitroso) are cytotoxic since they alkylate DNA and are capable of forming DNA-DNA interstrand crosslinks [153–155].
Metagenomic bioprospecting of novel oxygen insensitive nitroreductase for degradation of nitro aromatic compounds
2019, International Biodeterioration and BiodegradationRational design of an AKR1C3-resistant analog of PR-104 for enzyme-prodrug therapy
2016, Biochemical Pharmacology
Copyright © 1992 Published by Elsevier Inc.